A carregar...
Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration
BACKGROUND: Monoclonal antibodies targeting vascular endothelial growth factor (VEGF), such as bevacizumab, are administered intravitreally for the treatment of wet or exudative age-related macular degeneration (ARMD). Systemic use of bevacizumab has been linked to a wide range of renal adverse effe...
Na minha lista:
| Publicado no: | J Nephropathol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Society of Diabetic Nephropathy Prevention
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607973/ https://ncbi.nlm.nih.gov/pubmed/28975092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/jnp.2017.23 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...